Effect of streptokinase-streptodornase on peritoneal talc adhesions and granulomas; experimental study.

STREPTOKINASE-streptodornase mixtures (Sk-Sd) have been used in a variety of clinical conditions characterized by the presence of purulent exudates or coagulated blood. The results obtained by local application or by instillation have been favorable in thoracic empyema, hemothorax and pleural effusions,* gangrene of the extremities,9infected sinus tracts,† osteomyelitis,9tuberculous meningitis and adenitis,‡ burns,16and miscellaneous soft tissue infections.§ The data suggest that streptokinase-streptodornase mixtures exert a double action. The streptokinase, in the presence of a serum component, lyses fibrin.∥ The streptodornase depolymerizes desoxyribonucleoprotein which accumulates in purulent exudates from the nuclei of dead cells.¶ The final result is a liquefaction of purulent or clotted material which is readily removed. The present experiments were initiated to study the effects of Sk-Sd on peritoneal adhesions. It was assumed that these enzymes liquefy fibrinous and nucleoprotein exudates and, thus, that they might prevent peritoneal adhesions which develop from such

[1]  Gaensler Ea,et al.  Streptokinase-streptodornase in the treatment of extrapleural hematoma complicating extrapleural pneumothorax. , 1951 .

[2]  P. Long,et al.  Clinical experience with streptokinase and streptodornase. , 1951, Journal of the American Medical Association.

[3]  J. Macfarlane,et al.  Adjuvants to streptomycin in treating tuberculous meningitis in children. , 1950, Lancet.

[4]  S. Sherry,et al.  The extent of the enzymatic degradation of desoxyribonucleic acid (DNA) in purulent exudates by streptodornase. , 1950, The Journal of clinical investigation.

[5]  M. Rothman,et al.  Prevention of Postoperative Adhesions in Rabbits with Streptococcal Metabolites.∗ , 1950, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[6]  A. Goldman Medical and surgical decortication of the pleura in chronic pleural effusions. , 1950, The Journal of laboratory and clinical medicine.

[7]  P. Bazeley,et al.  THE USE OF STREPTOKINASE IN THE TREATMENT OF TUBERCULOUS MENINGITIS , 1950, The Medical journal of Australia.

[8]  A. Johnson Cytological studies in association with local injections of streptokinase-streptodornase into patients. , 1950, The Journal of clinical investigation.

[9]  C. Read,et al.  The utilization of streptokinase-streptodornase in a patient with hemopneumothorax and a patient with postpneumonectomy sanguineous coagulum. , 1950, The Journal of thoracic surgery.

[10]  W. Tillett,et al.  The use of streptokinase-streptodornase in the treatment of hemothorax. , 1950, The Journal of thoracic surgery.

[11]  C. J. McSweeney The treatment of tuberculous meningitis , 1950, Tubercle.

[12]  J. Harold,et al.  Massive haemothorax in artificial pneumothorax treated with streptokinase. , 1950, The British journal of tuberculosis and diseases of the chest.

[13]  G. Hazlehurst Anti (streptococcal) desoxyribonuclease. Occurrence in the sera of patients treated with streptococcal concentrates containing streptodornase. , 1950, Journal of immunology.

[14]  W. Tillett,et al.  Streptococcal enzymatic debridement. , 1950, Annals of surgery.

[15]  I. Cathie Streptomycin-streptokinase treatment of tuberculous meningitis. , 1949, Lancet.

[16]  W. Tillett,et al.  THE EFFECT IN PATIENTS OF STREPTOCOCCAL FIBRINOLYSIN (STREPTOKINASE) AND STREPTOCOCCAL DESOXYRIBONUCLEASE ON FIBRINOUS, PURULENT, AND SANGUINOUS PLEURAL EXUDATIONS. , 1949, The Journal of clinical investigation.

[17]  W. Tillett,et al.  Streptococcal Desoxyribonuclease , 1948, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[18]  L. R. Christensen STREPTOCOCCAL FIBRINOLYSIS: A PROTEOLYTIC REACTION DUE TO A SERUM ENZYME ACTIVATED BY STREPTOCOCCAL FIBRINOLYSIN , 1945, The Journal of general physiology.